Xuetongsu ameliorates synovial inflammatory hyperplasia in rheumatoid arthritis by inhibiting JAK2/STAT3 and NF-κB signaling pathways
2024 · Journal of Ethnopharmacology · 15 citations
https://doi.org/10.1016/j.jep.2024.118786
Y
Yuxin Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
529
Citations
11
h-index
15
i10-index
Yuxin Chen is an academic researcher from Zhejiang Chinese Medical University. The author has contributed to research in topics: Immune cells in cancer & Cancer Immunotherapy and Biomarkers & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 11, co-authored 40 publications.
ORCID: 0000-0002-5906-2877Papers by this author
worksThe effect of different ferrule heights and crown-to-root ratios on fracture resistance of endodontically-treated mandibular premolars restored with fiber post or cast metal post system: an in vitro study
2023 · BMC Oral Health · 11 citations
https://doi.org/10.1186/s12903-023-03053-4
Secreted frizzled-related protein 1 (SFRP1) gene methylation changes in the human lung adenocarcinoma cells treated with L-securinine
2017 · Journal of Asian Natural Products Research · 9 citations
https://doi.org/10.1080/10286020.2017.1329828
Ectopic expression of NKG7 enhances CAR-T function and improves the therapeutic efficacy in liquid and solid tumors
2024 · Pharmacological Research · 7 citations
https://doi.org/10.1016/j.phrs.2024.107506
Effective extraction of Xuetongsu and its role in preventing RA synovial hyperplasia by targeting synovial cell migration and apoptosis
2024 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-024-73471-z
Homologous targeted neutrophils-liposome system for pyroptosis-enhanced antitumor immunotherapy of triple-negative breast cancer
2025 · Materials Today Bio · 3 citations
https://doi.org/10.1016/j.mtbio.2025.101904
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat